Plain-English translation of NCT05386719 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial creates a structured screening program for women who have finished breast cancer treatment. Researchers want to check how common heart disease risk factors and metabolic problems (like prediabetes, diabetes, and high cholesterol) are in breast cancer survivors, and whether connecting you with support programs helps improve these conditions over time.
Breast cancer survivors often develop heart and metabolic health problems as a side effect of cancer treatment or due to other risk factors, but many don't receive organized screening or management. This trial aims to catch these problems early and connect patients with helpful resources and support programs.
You likely qualify if…
You likely don't qualify if…
You will complete health screening tests to check your blood sugar, cholesterol, and other heart disease risk factors at the start of the study. If the screening finds any concerns, you'll be connected with support programs and resources at Johns Hopkins to help manage them. You'll return for follow-up visits at 6 and 12 months to see how you're doing and track changes in your health, quality of life, and symptoms.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
United States
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
Private Philanthropic Funds
Enrollment target
~450 participants
Started
June 2022
Primary completion
September 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Hopkins Breast Trials
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.